Analyst Bill Sutherland works at BENCHMARK and is focused on the Industrials sector with 166 price targets and ratings documented since 2017 spanning on 17 stocks. Analyst's average stock valuation to be materialised ratio is 32.7% with an average time for price targets to be met of 136.18 days.
Most recent stock forecast was given on OMCL, Omnicell, Inc at 03-Nov-2022.
Bill Sutherland best performing recommendations are on YCBD (CBDMD, INC).
The best stock recommendation documented was for TRHC (TABULA RASA HEALTHCARE, INC) at 11/4/2020. The price target of $55 was fulfilled within 71 days with a profit of $23.94 (77.08%) receiving and performance score of 10.86.
Average potential price target upside